Pathological and histochemical studies were made to clarify the response to an aromatic retinoids (Ro 10-1670, Ro 10-9359) of the papilloma and carcinoma in hamster cheek pouch and mouse dorsal skin. The sizes of papilloma and carcinoma were remarkably reduced or completely regressed following systemic and topical administration of the aromatic retinoids. The antitumor effects increased in proportion to the frequency of administration than doses and were showed no side effects. Tumor tissues responded remarkably to the aromatic retinoids indicated an irregular keratinization including loss of hornified cells, nuclear vacuolization and inflammatory infiltrates which located in the border layer between stromas and neoplastic epithelia. Histochemically, tumor tissues which intensely affected by drugs were characterized by the presence of abundant acid phosphatase active cells. Those acid phosphatase active cells may be consisted of tumor cells, histiocytes and fibroblasts. In the electrocytochemical study acid phosphatase (a lysosomal marker enzyme) activity was found in epithelial tumor cells and fibroblasts. These results were indicated that epithelial tumor regression by aromatic retinoids the might be due to the accelerated lysosomal activity in the tumor cells and fibroblasts.

9,10-Dimethyl-1,2-benzanthracene↗

PubMed1982

[Evans' syndrome with various SLE-specific serological reactions in a child].

Explore the source record for details and available documents.

Adolescent↗

PubMed1982

[Organized activities by families caring for patients with senile dementia. Discussion: a need for assistance by public health nurses, an appeal by the families].

Explore the source record for details and available documents.

Aged↗

PubMed1982

[In vitro effect of the lithium on the neutrophil carbohydrate metabolism and NBT reduction (author's transl)].

Explore the source record for details and available documents.

Glucose↗

PubMed1981

[Effectiveness of acetylspiramycin for Mycoplasma pneumonia in children (author's transl)].

The clinical efficacy and safety of acetylspiramycin for Mycoplasma pneumonia in children were studied at a dose level of 50 mg/kg/day q.i.d. and the following results were obtained. Acetylspiramycin showed effect in 24 patients out of 25 (96.0%). The level of transminase was increased in 3 cases on admission. One of them was an uneffective case, and eruption was seen after administrating the drug. Diarrhea and poor appetite were observed in one case as side effects, and they were controlled easily. It may be concluded from these results acetylspiramycin was relatively free from side effects and considered to be useful for Mycoplasma pneumonia.

Age Factors↗

PubMed1981